Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
BMS-094
Casualties of an R&D war? Hep C trial patients accuse Bristol-Myers of recklessness
Casualties of an R&D war? Hep C trial patients accuse Bristol-Myers of recklessness
Fierce Biotech
BMS-094
Bristol-Myers Squibb
hepatitis C
R&D
Big Pharma Failures Light the Way to Change
Big Pharma Failures Light the Way to Change
Forbes
Alzheimer's disease
BMS-094
Bristol-Myers Squibb
FDA
Rethinking Idenix Pharma in Wake of Bristol's Hep C Blow Up
Rethinking Idenix Pharma in Wake of Bristol's Hep C Blow Up
TheStreet.com
BMS-094
Bristol-Myers Squibb
hepatitis C
Idenix
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT